title: Increased intracellular survival of Mycobacterium smegmatis containing the Mycobacterium leprae thioredoxin-thioredoxin reductase gene.
abstract: The thioredoxin (Trx) system of Mycobacterium leprae is expressed as a single hybrid protein containing thioredoxin reductase (TR) at its N terminus and Trx at its C terminus. This hybrid Trx system is unique to M. leprae, since in all other organisms studied to date, including other mycobacteria, both TR and Trx are expressed as two separate proteins. Because Trx has been shown to scavenge reactive oxygen species, we have investigated whether the TR-Trx gene product can inhibit oxygen-dependent killing of mycobacteria by human mononuclear phagocytes and as such could contribute to mycobacterial virulence. The gene encoding M. leprae TR-Trx was cloned into the apathogenic, fast-growing bacterium Mycobacterium smegmatis. Recombinant M. smegmatis containing the gene encoding TR-Trx was killed to a significantly lesser extent than M. smegmatis containing the identical vector with either no insert or a control M. leprae construct unrelated to TR-Trx. Upon phagocytosis, M. smegmatis was shown to be killed predominantly by oxygen-dependent macrophage-killing mechanisms. Coinfection of M. smegmatis expressing the gene encoding TR-Trx together with Staphylococcus aureus, which is known to be killed via oxygen-dependent microbicidal mechanisms, revealed that the TR-Trx gene product interferes with the intracellular killing of this bacterium. A similar coinfection with Streptococcus pyogenes, known to be killed by oxygen-independent mechanisms, showed that the TR-Trx gene product did not influence the oxygen-independent killing pathway. The data obtained in this study suggest that the Trx system of M. leprae can inhibit oxygen-dependent killing of intracellular bacteria and thus may represent one of the mechanisms by which M. leprae can deal with oxidative stress within human mononuclear phagocytes.
authors.affiliation: Department of Immunohematology and Blood Bank, Leiden University Hospital, The Netherlands. Wieles@imm.unibe.ch
authors.forename: B
authors.initials: B
authors.lastname: Wieles
authors.forename: T H
authors.initials: TH
authors.lastname: Ottenhoff
authors.forename: T M
authors.initials: TM
authors.lastname: Steenwijk
authors.forename: K L
authors.initials: KL
authors.lastname: Franken
authors.forename: R R
authors.initials: RR
authors.lastname: de Vries
authors.forename: J A
authors.initials: JA
authors.lastname: Langermans
mesh_terms: D001426:Bacterial Proteins / Q000235:genetics* / Q000502:physiology; D005798:Genes, Bacterial; D009161:Mycobacterium / Q000235:genetics* / Q000472:pathogenicity / Q000502:physiology*; D009166:Mycobacterium leprae / Q000235:genetics* / Q000502:physiology; D010586:Phagocytes / Q000502:physiology; D011995:Recombination, Genetic; D013880:Thioredoxin-Disulfide Reductase / Q000235:genetics*; D013879:Thioredoxins / Q000235:genetics*
chemical_list: D001426:Bacterial Proteins; C096391:thioredoxin-thioredoxin reductase hybrid protein, Mycobacterium leprae; D013879:Thioredoxins; D013880:Thioredoxin-Disulfide Reductase